Preliminary results regarding other bAbs that redirect T cells have been reported, suggesting SC injection did reduce the maximum concentration associated with CRS with high bioavailability, SC dosing is therefore a preferable route of administration for mitigating CRS and increasing the dose intensity [108, 109]. Here, ODC1 is linked to congenital rubella syndrome.